← All Theravance Biopharma, INC filings

Theravance Biopharma, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
TBPH
Theravance Biopharma, INC
SCHEDULE: Theravance Biopharma Merger Complete, Shares Cancelled
Weiss Asset Management LP and related entities report zero beneficial ownership of Theravance Biopharma, Inc. ordinary shares following the company's merger with Zymeworks Inc. and subsequent share cancellation.
NASDAQ
TBPH
Theravance Biopharma, INC
SCHEDULE: Weiss Asset Management Boosts Theravance Biopharma Stake
Weiss Asset Management LP and its affiliates have increased their beneficial ownership in Theravance Biopharma, Inc. to 14.5% of outstanding shares.